University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Genvoya

Genvoya (Elvitegravir + Cobicistat + tenofovir alafenamide + Emtriva)

Type of Drug: Fixed-Dose Combination
Fixed-dose combinations combine the most commonly prescribed doses of 2 or more medications into a single pill.

Approved adult dosing

Elvitegravir 150 mg + Cobicistat 150 mg + tenofovir alafenamide 10 mg + Emtriva 200 mg in a single tablet

  • one tablet

    Genvoya

    Genvoya

Note: Stribild

Notes on taking this medication

  • Take with food (do not take without food)
  • Stribild interacts with some over the counter antacid medicines; check with your medical provider before using these medicines
  • Stribild can interact with other drugs; consult your medical provider

Side effects

    Stribild has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug

See accompanying chart: Tips for Common Side Effects

Same side effects as

Elvitegravir

  • Diarrhea, headache

Cobicistat

  • Nausea, diarrhea
  • Headache
  • Fatigue
  • Elevation in blood creatinine levels (this is used to assess kidney function; your provider will monitor creatinine)

Tenofovir alafenamide (TAF)

  • Gassiness; abdominal discomfort; nausea; diarrhea
  • Possible kidney impairment
  • TAF is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

Emtriva

  • Skin discoloration (particularly in dark-skinned people)
  • Headache; diarrhea; nausea
  • Emtriva is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Contents
Scroll over drug name to see other names for the drug.